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Introduction
Migraine with aura (MA) is a common disorder affecting
about 30% of migrainous patients [1]. MA is codified in
the ICHD-III classification [2] and typical auras are known
and easily recognized in particular by patients chronically
suffering of MA. Sometimes even these patients present to
the Emergency Department (ED) because their auras are
different from usual. The more frequent causes are abnor-
mal prolongation, increased frequency of recurrence or
the developing of new symptoms, particularly in patients
that presented in the past only visual auras. Generally
these conditions are not dangerous, but ambiguous situa-
tions may occur, with the possibility of considering as
trivial a potentially serious disorder, as in our patient.
Case report
A 41-year old male suffered since his youth of sporadic
episodes of migrainous headache preceded, 3-6 times/year,
by typical auras consisting of a spreading right-sided visual
field associated, after about ten minutes from the onset,
with paresthesias ascending along the right arm. In 2010
he referred a transitory increase in frequency of these epi-
sodes and the MRI performed was normal. In November
2012 he experienced a transitory increase in frequency of
the episodes, but also noticed an extension of the ascend-
ing paresthesia to his right leg. Duration of aura slightly
increased, and was followed by “usual” headache. Evalu-
ated in the ED, a brain-CT (b-CT) scan demonstrated the
presence of a cortical-subcortical hemorrhage in the left
posterior parietal lobe. During hospitalization, EEG and
four vessel cerebral angiographies were normal. In May
2013 after a 6-month free-of-episodes period, he went
again to the ED for several daily episodes of visual and
paresthetic aura, involving the right arm; b-CT and MRI
were negative for acute lesions; EEG was normal.
Discharged with topiramate 50 mg/day, the patient pre-
sented in the following years only sporadic episodes of
visual aura but in March 2015 he experienced again a
recrudescence of daily episodes of aura. Admitted to our
Neurology Ward, b-CT scan, EEG and MRI were unre-
markable for new events.
Discussion
In the ICHD-III classification [2] we find a group of MA
complications as persistent aura without infarction and
migrainous infarction; we performed a literature research
to find if there were other possible modifications in typical
aura presentation that could represent a risk factor of a
complication as in the case here reported. The data about
this topic are lacking and we think that prospective studies
on this matter are desirable.
Written informed consent to publication was obtained
from the patient(s).
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